Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats

Vinicia C. Biancardi, Sook J. Son, Patrick M. Sonner, Hong Zheng, Kaushik P Patel, Javier E. Stern

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Neurohumoral activation, a hallmark in heart failure (HF), is linked to the progression and mortality of HF patients. Thus, elucidating its precise underlying mechanisms is of critical importance. Other than its classic peripheral vasodilatory actions, the gas NO is a pivotal neurotransmitter in the central nervous system control of the circulation. While accumulating evidence supports a contribution of blunted NO function to neurohumoral activation in HF, the precise cellular sources, and NO synthase (NOS) isoforms involved, remain unknown. Here, we used a multidisciplinary approach to study the expression, cellular distribution, and functional relevance of the endothelial NOS isoform within the hypothalamic paraventricular nucleus in sham and HF rats. Our results show high expression of endothelial NOS in the paraventricular nucleus (mostly confined to astroglial cells), which contributes to constitutive NO bioavailability, as well as tonic inhibition of presympathetic neuronal activity and sympathoexcitatory outflow from the paraventricular nucleus. A diminished endothelial NOS expression and endothelial NOS-derived NO availability were found in the paraventricular nucleus of HF rats, resulting, in turn, in blunted NO inhibitory actions on neuronal activity and sympathoexcitatory outflow. Taken together, our study supports blunted central nervous system endothelial NOS-derived NO as a pathophysiological mechanism underlying neurohumoral activation in HF.

Original languageEnglish (US)
Pages (from-to)454-463
Number of pages10
JournalHypertension
Volume58
Issue number3
DOIs
StatePublished - Sep 1 2011

Fingerprint

Nitric Oxide Synthase Type III
Nitric Oxide Synthase
Central Nervous System
Heart Failure
Paraventricular Hypothalamic Nucleus
Protein Isoforms
Biological Availability
Neurotransmitter Agents
Gases
Mortality

Keywords

  • Heart failure
  • NO
  • astrocyte
  • hypothalamus
  • sympathetic

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats. / Biancardi, Vinicia C.; Son, Sook J.; Sonner, Patrick M.; Zheng, Hong; Patel, Kaushik P; Stern, Javier E.

In: Hypertension, Vol. 58, No. 3, 01.09.2011, p. 454-463.

Research output: Contribution to journalArticle

Biancardi, Vinicia C. ; Son, Sook J. ; Sonner, Patrick M. ; Zheng, Hong ; Patel, Kaushik P ; Stern, Javier E. / Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats. In: Hypertension. 2011 ; Vol. 58, No. 3. pp. 454-463.
@article{6d8ec64f89a04d5fa70ac08eba8c38e0,
title = "Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats",
abstract = "Neurohumoral activation, a hallmark in heart failure (HF), is linked to the progression and mortality of HF patients. Thus, elucidating its precise underlying mechanisms is of critical importance. Other than its classic peripheral vasodilatory actions, the gas NO is a pivotal neurotransmitter in the central nervous system control of the circulation. While accumulating evidence supports a contribution of blunted NO function to neurohumoral activation in HF, the precise cellular sources, and NO synthase (NOS) isoforms involved, remain unknown. Here, we used a multidisciplinary approach to study the expression, cellular distribution, and functional relevance of the endothelial NOS isoform within the hypothalamic paraventricular nucleus in sham and HF rats. Our results show high expression of endothelial NOS in the paraventricular nucleus (mostly confined to astroglial cells), which contributes to constitutive NO bioavailability, as well as tonic inhibition of presympathetic neuronal activity and sympathoexcitatory outflow from the paraventricular nucleus. A diminished endothelial NOS expression and endothelial NOS-derived NO availability were found in the paraventricular nucleus of HF rats, resulting, in turn, in blunted NO inhibitory actions on neuronal activity and sympathoexcitatory outflow. Taken together, our study supports blunted central nervous system endothelial NOS-derived NO as a pathophysiological mechanism underlying neurohumoral activation in HF.",
keywords = "Heart failure, NO, astrocyte, hypothalamus, sympathetic",
author = "Biancardi, {Vinicia C.} and Son, {Sook J.} and Sonner, {Patrick M.} and Hong Zheng and Patel, {Kaushik P} and Stern, {Javier E.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.111.175810",
language = "English (US)",
volume = "58",
pages = "454--463",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats

AU - Biancardi, Vinicia C.

AU - Son, Sook J.

AU - Sonner, Patrick M.

AU - Zheng, Hong

AU - Patel, Kaushik P

AU - Stern, Javier E.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Neurohumoral activation, a hallmark in heart failure (HF), is linked to the progression and mortality of HF patients. Thus, elucidating its precise underlying mechanisms is of critical importance. Other than its classic peripheral vasodilatory actions, the gas NO is a pivotal neurotransmitter in the central nervous system control of the circulation. While accumulating evidence supports a contribution of blunted NO function to neurohumoral activation in HF, the precise cellular sources, and NO synthase (NOS) isoforms involved, remain unknown. Here, we used a multidisciplinary approach to study the expression, cellular distribution, and functional relevance of the endothelial NOS isoform within the hypothalamic paraventricular nucleus in sham and HF rats. Our results show high expression of endothelial NOS in the paraventricular nucleus (mostly confined to astroglial cells), which contributes to constitutive NO bioavailability, as well as tonic inhibition of presympathetic neuronal activity and sympathoexcitatory outflow from the paraventricular nucleus. A diminished endothelial NOS expression and endothelial NOS-derived NO availability were found in the paraventricular nucleus of HF rats, resulting, in turn, in blunted NO inhibitory actions on neuronal activity and sympathoexcitatory outflow. Taken together, our study supports blunted central nervous system endothelial NOS-derived NO as a pathophysiological mechanism underlying neurohumoral activation in HF.

AB - Neurohumoral activation, a hallmark in heart failure (HF), is linked to the progression and mortality of HF patients. Thus, elucidating its precise underlying mechanisms is of critical importance. Other than its classic peripheral vasodilatory actions, the gas NO is a pivotal neurotransmitter in the central nervous system control of the circulation. While accumulating evidence supports a contribution of blunted NO function to neurohumoral activation in HF, the precise cellular sources, and NO synthase (NOS) isoforms involved, remain unknown. Here, we used a multidisciplinary approach to study the expression, cellular distribution, and functional relevance of the endothelial NOS isoform within the hypothalamic paraventricular nucleus in sham and HF rats. Our results show high expression of endothelial NOS in the paraventricular nucleus (mostly confined to astroglial cells), which contributes to constitutive NO bioavailability, as well as tonic inhibition of presympathetic neuronal activity and sympathoexcitatory outflow from the paraventricular nucleus. A diminished endothelial NOS expression and endothelial NOS-derived NO availability were found in the paraventricular nucleus of HF rats, resulting, in turn, in blunted NO inhibitory actions on neuronal activity and sympathoexcitatory outflow. Taken together, our study supports blunted central nervous system endothelial NOS-derived NO as a pathophysiological mechanism underlying neurohumoral activation in HF.

KW - Heart failure

KW - NO

KW - astrocyte

KW - hypothalamus

KW - sympathetic

UR - http://www.scopus.com/inward/record.url?scp=80051940610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051940610&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.111.175810

DO - 10.1161/HYPERTENSIONAHA.111.175810

M3 - Article

VL - 58

SP - 454

EP - 463

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -